SREBF1 and fatty liver disease: Animal studies have shown that increased hepatic SREBP-1c is associated with insulin resistance, diabetes and hepatic steatosis, partially by the enhanced synthesis of lipotoxic saturated fatty acids and increased hepatic gluconeogenesis23, 24.